Bioequivalence and Bioavailability Forum

The International Generic and Biosimilar medicines Association (IGBA) and Medicines for Europe will be co-hosting the

3^rd Bio­equi­va­lence Con­ference,

scheduled to take place on 26 February 2025 as an in-person event at the Hilton Amsterdam Airport Schiphol, in Amsterdam, the Netherlands.

The conference will provide a platform for an exchange of views between industry, regulators, and academia and will cover the following topics:

1. International harmonisation of bioequivalence: current status and next steps (ICH M13A implementation and hot topics for M13C)
   
2. Model-informed approaches supporting bioequivalence in generic medicines development
   
3. Compliance and oversight in BE
   
4. Single global development of generic medicines: enabling patient access

Further information along with the draft programme and registration details can be found here.

---

Edit [Helmut]